Testicular Cancer - Results from #180

[Onco-TESE and testicular cancer]. February 25, 2021

Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review. February 24, 2021

Intricacies of Radiographic Assessment in Testicular Germ Cell Tumors. February 19, 2021

Radiotherapy after testis-sparing surgery for seminoma in monorchid patients: safety and efficacy. February 18, 2021

LUZP4 autoantibody: A novel germ cell tumor and paraneoplastic biomarker. February 17, 2021

Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study. February 16, 2021

Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer. February 15, 2021

Evaluating the molecular diagnostic yield of joint genotyping-based approach for detecting rare germline pathogenic and putative loss-of-function variants. February 12, 2021

Identification of new biomarkers in immune microenvironment of testicular germ cell tumour. February 10, 2021

Identifying the Need to Discuss Infertility Concerns Affecting Testicular Cancer Patients: An Evaluation (INDICATE Study). February 9, 2021

Serum polychlorinated biphenyl (PCB) levels and risk of testicular germ cell tumors: A population-based case-control study in Connecticut and Massachusetts. February 8, 2021

Potential biomarkers for testicular germ cell tumour: Risk assessment, diagnostic, prognostic and monitoring of recurrence. February 5, 2021

A Patient Centric Pathway for Testicular Cancer - A Multicentre Study Investigating The Uptake of Semen Cryopreservation and Impact on Treatment. February 4, 2021

Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress. February 3, 2021

Long-Term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-Based Cohort Study. February 2, 2021

Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors. February 1, 2021

Blood testis barrier revisited-Analysis of post-chemotherapy germ cell tumor orchidectomy and retroperitoneal lymph node dissection specimens. January 28, 2021

Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors. January 27, 2021

Assessing Health-Related Quality of Life Among Survivors of Testicular Cancer: A Systematic Review. January 22, 2021

Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest. January 20, 2021

Page 10 of 77

email news signup